Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals’ views

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

(2015) Hein Heidbuchel et al.   EUROPACE

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

(2015) Gregory Y.H. Lip et al.   EUROPACE

New Oral Anticoagulants in Practice: Pharmacological and Practical Considerations

(2014) Yishen Wang et al.   American Journal of Cardiovascular Drugs

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use

(2014) Thomas Wilke et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control

(2014) Andrej Janzic et al.   PHARMACOECONOMICS

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

(2013) Gregory Y.H. Lip et al.   EUROPACE

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation

(2011) N. Riva et al.   AGE AND AGEING

Development of a Computerised Antithrombotic Risk Assessment Tool (CARAT) to optimise therapy in older persons with atrial fibrillation

(2011) Beata V Bajorek et al.   AUSTRALASIAN JOURNAL ON AGEING

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Could Geriatric Characteristics Explain the Under-Prescription of Anticoagulation Therapy for Older Patients Admitted with Atrial Fibrillation?

(2010) Sandra De Breucker et al.   DRUGS & AGING

Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain

(2009) Diane Wild et al.   Expert Review of Pharmacoeconomics & Outcomes Research